The Latest Breaking News from MCK

The medical industry has undergone significant expansion in recent times, and is projected to continue growing due to the increasing number of chronic diseases and the swift adoption of technology. Hence, I think fundamentally strong medical stocks McKesson (MCK), Centene (CNC), Cardinal Health (CAH), and Nature’s Sunshine Products (NATR) might…

Recent rhetoric from the Federal Reserve, the collapse of the Silicon Valley Bank, and strong economic data have now resulted in an extremely volatile market backdrop. Against this, adding fundamentally sound stocks Bristol-Myers Squibb (BMY), General Motors (GM), McKesson Corp. (MCK), Cardinal Health (CAH), and American Vanguard (AVD) to your…

Aggressive rate hikes have pressured growth stocks since last year. However, growth stocks could prove to be promising investments this year in the hopes of the Fed pulling off a “soft landing.” Therefore, it could be wise for investors to buy fundamentally strong growth stocks Salesforce, Inc. (CRM), McKesson Corp.…

Rising bond yields and a strong dollar are dampening the stock market rally. Also, experts see a significant chance of inflation rebounding. Therefore, fundamentally strong stocks, Cigna (CI), McKesson (MCK), Pilgrim’s Pride (PPC), and Global Partners (GLP), which can potentially withstand any market conditions, could be ideal investments now. Read…

In response to the inflow of favorable macro data and the Fed's moderating rate hikes, investor optimism rekindled. This might aid growth stocks to stage a solid recovery in the near term. Against this backdrop, fast-growing quality stocks McKesson Corporation (MCK) and ADT Inc. (ADT) might be solid buys for…

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….

With expanding medical needs and technological advancements, the healthcare industry’s prospects look impressive. Moreover, healthcare stocks tend to perform relatively well, irrespective of economic conditions, thanks to the inelastic demand for their products and services. Therefore, we think Nature’s Sunshine Products (NATR), Abbott Laboratories (ABT), Humana (HUM), Molina Healthcare (MOH),…

The medical industry is poised for growth this year, driven by expanding medical needs and increasing federal support. Moreover, the industry is expected to thrive in times of uncertainty due to steady demand. Thus, quality medical stocks McKesson Corp. (MCK) and Cardinal Health (CAH) could be ideal buys this year.…

Popular healthcare service provider McKesson (MCK) has delivered robust returns despite the market turbulence over the past year. Moreover, MCK’s solid fundamentals should help it to sustain its momentum. Thus, the stock might be an ideal buy for 2023. Keep reading.